Pituitary adenoma epidemiology and demographics

Pituitary adenoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pituitary adenoma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural history, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pituitary adenoma epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pituitary adenoma epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pituitary adenoma epidemiology and demographics
CDC on Pituitary adenoma epidemiology and demographics
Pituitary adenoma epidemiology and demographics in the news
Blogs on Pituitary adenoma epidemiology and demographics
Directions to Hospitals Treating Pituitary adenoma
Risk calculators and risk factors for Pituitary adenoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]

Overview

The prevalence of pituitary adenoma is approximately 100 per 100,000 individuals worldwide. In the USA, the incidence pituitary adenoma is approximately 3.12 per 100,000 individuals.

Epidemiology and Demographics

Prevalence

• The prevalence of pituitary adenoma is approximately 100 per 100,000 individuals worldwide.
• Autopsy prevalence of pituitary adenoma is approximately 15,000 per 100,000 individuals worldwide.

Incidence

• In the USA, the incidence of the pituitary adenoma is approximately 3.12 per 100,000 individuals.
• The actual incidence is much higher as most patients remain asymptomatic for long time.